MRC1 and COVID-19: The lowered TM in COVID-19 may be a consequence of the enhanced clearance of TM-containing glycoconjugates via the mannose receptor (CD206) which has been found to be highly expressed on alveolar macrophages in lung inflammatory conditions associated with the disease.41